pildralazine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
antihypertensives, hydrazinephthalazine derivatives 3471 64000-73-3

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • pildralazine
  • propyldazine
  • Molecular weight: 197.24
  • Formula: C8H15N5O
  • CLOGP: 0.56
  • LIPINSKI: 0
  • HAC: 6
  • HDO: 3
  • TPSA: 87.30
  • ALOGS: -1.48
  • ROTB: 4

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

None

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 6.74 Basic
pKa2 3.74 Basic
pKa3 2.87 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
C0072178 UMLSCUI
CHEBI:134858 CHEBI
CHEMBL2107172 ChEMBL_ID
68829 PUBCHEM_CID
5202 INN_ID
FU2BGC781U UNII

Pharmaceutical products:

None